Company intelligence / Profile preview

Gadea Pharmaceutical Group

Valladolid, Castile and León / Castilla y León, Spaingadeafilms.com ↗

Ownership: Private
Development stage: Commercial

Overview

Gadea Pharmaceutical Group was a Spanish pharmaceutical company specializing in the technical development and large-scale production of active pharmaceutical ingredients (APIs) and finished drug forms. Its Crystal Pharma division was recognized for commercial API production—especially steroids, high-potency hormones, and sterile steroids. In July 2015, it was acquired by Albany Molecular Research Inc. (AMRI) for $174 million. At acquisition it had over $83 million in annual revenue with more than 400 customers across 70 countries[2][5][8].

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Not specifically listed; served >400 pharma customers globally

Beyond the preview

Go deeper on Gadea Pharmaceutical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gadea Pharmaceutical Group.

Explore the full profile